09.11.2018 - AstraZeneca, the British-Swedish pharma major, is selling rights outside the US for the respiratory drugs Alvesco, Omnaris, and Zetonna. Buyer is Zug, Switzerland-based Covis...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)